3 Reasons to Buy Novo Nordisk Stock Right Now

The bigger they are, the harder they fall. That saying applies to Novo Nordisk (NYSE: NVO) and its poor performance over the past year.The company was one of the largest healthcare stocks, and a leader in the emerging and fast-growing market for weight management medicines, coming into 2024. However, due to a series of setbacks, the stock has lost more than 40% of its value over the trailing-12-month period.Despite Novo Nordisk's issues, though, there remain excellent reasons to invest in the stock. Below are just three of them.Continue readingWeiter zum vollständigen Artikel bei MotleyFool Weiter zum vollständigen Artikel bei MotleyFool